AMYGDALA NEURO

AMYGDALA NEURO, based in China and facing the world, is developing a new generation of neuromodulation and brain-computer interface technologies and products guided by clinical needs. Multiple products under research are aligned with cutting-edge global innovative technologies, achieving technological breakthroughs and filling industrial gaps. To date, the R&D team has overcome technical barriers in areas such as autonomous system design, electrode design, chip design, signal acquisition and decoding, algorithm development, and MRI compatibility. They have established a universal neuromodulation platform that incorporates some of the most advanced technologies available globally. Several products under development are the first of their kind in China and are about to enter the animal testing and clinical trial stages.